483 Abraxis Bioscience Mar 2002

483 Abraxis Bioscience Mar 2002

Randall Johnson FDA, Sue Lee Chan FDA, Caryn Mcnab FDA, Raymond Oji FDA$119.00 - Available Now

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 01 Mar 2002.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Mar 2002
  • Location: Phoenix, United States
  • FEI: 2025487
Add To Cart